4 ms·
Pfizer has more "surface area" but beyond that, no. Prosecutors love shooting fish in a barrel: it actually makes smaller biotech firms more attractive regulati
by spamizbad 4y ago
Pfizer has more "surface area" but beyond that, no. Prosecutors love shooting fish in a barrel: it actually makes smaller biotech firms more attractive regulation targets.
- johndhi 4y agoDisagree. Every civil prosecutor I've ever worked with wants a big "story." They are driven by headlines. Taking down local mom's pharmaco is the opposite of the narrative people want to read in the paper. We like the headline of this article: megacorp pfizer is evil. That's why we're in this thread, right?
- forgetfreeman 4y agoYou may disagree but the history of the Office of Inspector General crapping on sub-200 headcount biotech and pharma startups doesn't mesh with any of that. Keep in mind smaller firms don't put up anywhere near the fight a multinational like Pfizer is capable of, and the OIG knows this.